Autori: Popovic Lazar S
| Naslov | Real-world prevalence of PD-L1 positivity in early-stage/metastatic triple-negative breast cancer: primary results and pathology insights from the global retrospective observational VANESSA study (Article; Early Access) |
| Autori | D'arrigo Corrado ... Medic-Milijic Natasa ... Popovic Lazar S |
| Info | HISTOPATHOLOGY, (2026), vol. br. , str. - |
| Projekat | F. Hoffmann-La Roche Ltd. |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Treatment patterns and clinical outcomes according to PD-L1 status in >2000 patients with early-stage or metastatic triple-negative breast cancer treated in the real-world setting: VANESSA study results (Article) |
| Autori | Popovic Lazar S ... (broj koautora 18) |
| Info | BREAST, (2026), vol. 86 br. , str. - |
| Projekat | F. Hoffmann-La Roche Ltd. |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: |
| Naslov | Real-World Clinical Experience of First-Line Ribociclib Combined with an Aromatase Inhibitor in Metastatic Breast Cancer (Article) |
| Autori | Cvetanovic Ana S Jankovic Kristina B Stojkovic Ana S Zivkovic Nikola D Kostic Milos S Popovic Lazar S |
| Info | CANCERS, (2026), vol. 18 br. 2, str. - |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
| Naslov | Barriers related to adherence and implementation of the ESMO clinical practice guidelines: A survey provided by the ESMO community oncologists task force (Meeting Abstract) |
| Autori | Liposits GI Indini A Papakonstantinou A Tan ABT Petrova M Pellegrino B Scholl K Popovic Lazar S Van Halteren HK Tomas AJ Cunquero Brasiuniene B Bennouna J Smyth E Vidra RA |
| Info | ANNALS OF ONCOLOGY, (2025), vol. 36 br. , Suppl. 2, str. - |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
| Naslov | Prognostic immunotherapy score (PIS) in patients with advanced urothelial carcinoma treated with pembrolizumab: real-world data and validation from ARON-2 dataset (Article) |
| Autori | Rizzo Alessandro ... Popovic Lazar S ... (broj koautora 24) |
| Info | CLINICAL & EXPERIMENTAL METASTASIS, (2025), vol. 42 br. 5, str. - |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
| Naslov | Treatment Sequencing in Metastatic HR+/HER2-Breast Cancer: A Delphi Consensus (Review) |
| Autori | Popovic Lazar S Borstnar Simona Bozovic-Spasojevic Ivana M Cvetanovic Ana S Dedic-Plavetic Natalija Kaneva Radka Konsoulova Assia Matos Erika Tomic Snjezana Vrdoljak Eduard |
| Info | CANCERS, (2025), vol. 17 br. 9, str. - |
| Projekat | AstraZeneca Balkans |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
| Naslov | Real-world treatment patterns in patients with human epidermal growth factor receptor 2 (HER2) - positive early breast cancer in Serbia and Montenegro - HEReNA (Meeting Abstract) |
| Autori | Bozovic-Spasojevic Ivana M Milovic-Kovacevic Marijana M Lekic S Cvetanovic A Kolarov-Bjelobrk Ivana N Lucic J Andric Zoran G Milenkovic D ... Vukovic I Petronijevic M Calamac Marina D Djurmez Ognjen Djuric S Perduv V Radisavljevic M Popovic Lazar S |
| Info | BREAST, (2025), vol. 80 br. , Suppl. S, str. - |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
| Naslov | Sex as modifier of survival in patients with advanced urothelial cancer treated with pembrolizumab (Article) |
| Autori | Incorvaia Lorena ... Popovic Lazar S ... (broj koautora 30) |
| Info | SCIENTIFIC REPORTS, (2025), vol. 15 br. 1, str. - |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
| Naslov | Real-Life Impact of Enfortumab Vedotin or Chemotherapy in the Sequential Treatment of Advanced Urothelial Carcinoma: The ARON-2 Retrospective Experience (Article) |
| Autori | Rizzo Mimma ... Popovic Lazar S ... (broj koautora 25) |
| Info | CANCER MEDICINE, (2025), vol. 14 br. 4, str. - |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
| Naslov | Characteristics and clinical outcomes of breast cancer in young BRCA carriers according to tumor histology (Article) |
| Autori | Agostinetto Elisa ... Popovic Lazar S ... (broj koautora 42) |
| Info | ESMO OPEN, (2024), vol. 9 br. 10, str. - |
| Projekat | MAK Pharma; Agendia, Recordati; Amgen; AstraZeneca; Eisai; Eli Lilly; Takeda; Roche; Gilead Sciences; Gilead; Astra-Zeneca; Pfizer; Daiichi Sankyo; Italian Association of Medical Oncology |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
